LeMaitre Vascular, Inc. (LMAT) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped LMAT stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: LeMaitre Vascular demonstrates rapid revenue and product innovation-driven growth, coupled with strategic acquisitions and healthy fundamentals. While competition and regulatory concerns remain, the overall trajectory suggests above-market performance with significant long-term potential. Analysts maintain a favorable outlook. The saved 1-year distribution is P10 $95, P50 $125, and P90 $140.
Last analyzed · Model: gpt-4o
LeMaitre Vascular, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $95 | Pessimistic plausible scenario |
| P50 | $125 | Median scenario |
| P90 | $140 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
The company has shown strong revenue growth and industry expansion with innovative products. However, there are risks associated with competition and regulatory scrutiny.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this LMAT analysis generated?
March 16, 2026.
Is this a guaranteed LMAT prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full LMAT stock analysis · LMAT sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.